REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCHAL.L Regulatory News (CHAL)

  • There is currently no data for CHAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cost Control Measures and Allotment of Shares

6 Feb 2017 07:00

RNS Number : 0490W
Challenger Acquisitions Limited
06 February 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN.

 

For Immediate Release

6 February 2017

Challenger Acquisitions Limited

("Challenger" or the "Company")

 

Cost Control Measures and Allotment of Shares re Convertible Notes

 

Challenger Acquisitions Limited (LSE: CHAL) announces that it has commenced a strategy to implement specific cost control measures and to actively manage the conversion of a portion of its outstanding convertible notes.

 

Effective from 1 February 2017, Mark Gustafson, Chief Executive Officer of the Company, has agreed to a compensation arrangement of £1,000 per month until further notice. The board of directors has also been reduced to three members with the retirement of Markus Kameisis as an executive director. Mr. Kameisis retains his position as Chief Financial Officer of the Company. Going forward, the Company will continue to review public company costs to ensure these are minimised wherever possible.

 

The Company also announces that it has allotted 8,323,476 new Ordinary Shares of £0.01 each ("Share") on the conversion of £630,431 of the 12% unsecured convertible notes due 6 May 2017 (issued at 8.2p per share) and £50,000 of the unsecured convertible notes due 13 April 2018 (issued at 7.8p per share). An additional 15,536 Shares were allotted to settle interest of £1,274 due up until the date of conversion. These Shares were issued at a price of 8.2p per Share.

 

Application has been made to the Financial Conduct Authority ("FCA") for 8,339,012 Shares to be admitted to listing on the standard listing segment of the Official List and to the London Stock Exchange for such shares to be admitted to trading on the Main Market for listed securities. It is expected that Admission will become effective, and dealings in the new ordinary shares will commence, at or around 8.00a.m. on 9 February 2017.

 

Following this allotment, the total number of Shares in issue and the total number of voting rights in the Company is 31,218,745. There are no Shares held in treasury. The figure of 31,218,745 Shares and voting rights may be used by shareholders in the Company as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

Mark Gustafson, Challenger's Chief Executive Officer said: "Following the recent disposal of the Starneth business we believe it is prudent to minimise our public company costs until fees from the closing of Giant Observation Wheel projects commence. In line with this, we are currently exploring a number of prospective growth opportunities and we look forward to updating shareholders on these developments in due course. Alongside this, we will work actively with our note holders to reduce the level of convertible notes in our Company this year in order to ensure we are well positioned to build value for our shareholders."

 

This announcement contains inside information.

 

**ENDS**

 

For more information visit www.challengeracquisitions.com or enquire to:

 

Challenger Acquisitions Limited

Mark Gustafson

+1 604 454 8677

St Brides Partners Ltd (PR)

Lottie Brocklehurst, Charlotte Page

+44 (0) 20 7236 1177

finnCap (Financial Adviser and Broker)

Adrian Hargrave, James Thompson, Kate Bannatyne

+44 (0) 20 7220 0500

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESSMFDIFWSEIE
Date   Source Headline
17th May 20167:00 amRNSResult of AGM
16th May 20167:00 amRNSPurchase of Shares by Director
9th May 20167:00 amRNSPurchase of Shares by Director
3rd May 20167:00 amRNSPurchase of Shares by Director
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 20164:50 pmRNSAnnual Report and Notice of AGM
27th Apr 20167:00 amRNSFinal Results
26th Apr 20167:00 amRNSConvertible Notes Extension & Issue of £0.5m Note
13th Apr 20162:00 pmRNSAllotment of Shares re Convertible Loan Notes
31st Mar 20167:00 amRNSUpdate on Global Giant Observation Wheel Activity
24th Mar 20165:48 pmRNSFurther Re: Conversion of Convertible Loan Notes
21st Mar 20167:00 amRNSConversion of Convertible Loan Notes
9th Mar 201612:35 pmRNSPresenting at Shares Investor Evening
3rd Mar 20167:00 amRNSIssue of £0.5m convertible notes
22nd Feb 20167:00 amRNSUpdate on Giant Observation Wheel in Jakarta
5th Feb 20167:00 amRNSHolding(s) in Company
29th Jan 20165:00 pmRNSTotal Voting Rights
29th Jan 20167:00 amRNSIncreases Investment in New York Wheel
15th Jan 20167:00 amRNSAppointment of Financial Adviser
12th Jan 20167:00 amRNSAppointment of New Directors
7th Jan 20163:51 pmRNSAllotment of Shares and Options Granted
8th Dec 20158:00 amRNSReadmission to trading on London Stock Exchange
8th Dec 20158:00 amRNSCancellation - Challenger Acquisitions Limited
2nd Dec 20152:11 pmRNSPublication of Prospectus & Expected Readmission
30th Oct 201511:52 amRNSTotal Voting Rights
10th Sep 20155:30 pmRNSGrant of Options and Prospectus Update
28th Aug 20153:33 pmRNSHalf Yearly Report
5th Aug 201512:42 pmRNSHolding(s) in Company
30th Jul 20152:55 pmRNSFunding update, grant of options & issue of equity
21st Jul 20151:14 pmRNSHolding(s) in Company
16th Jul 20158:00 amRNSAcquisition of Starneth Completed
7th Jul 201512:34 pmRNSIssue of Equity
27th May 20153:31 pmRNSHolding(s) in Company
26th May 20159:25 amRNSInvestment, LOI and suspension
26th May 20159:10 amRNSSuspension Challenger Acquisitions Limited
20th May 20157:00 amRNSFunding Update
13th May 20155:23 pmRNSHolding(s) in Company
28th Apr 20158:00 amRNSProposed funding: up to £3m via convertible notes
7th Apr 201510:10 amRNSUK Investor Show
2nd Apr 20154:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20158:00 amRNSCorporation Agreement with Starneth signed
19th Feb 20157:00 amRNSAdmission to Trading and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.